Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation
多替拉韦与依非韦伦在12个月和24个月的维持率和病毒抑制率方面的比较:一项目标试验模拟
期刊:Infectious Diseases
影响因子:
doi:10.1080/23744235.2025.2557628
Zheng, Amy; Brennan, Alana T; Greener, Ross; Kileel, Emma M; Bor, Jacob; Venter, Willem D F; Murray, Eleanor J; Pisa, Pedro T; Goeieman, Bridgette; Fox, Matthew P; Maskew, Mhairi